Provider QP33-26 Update for New-to-Market Medical Drugs: lunsotogene parvec-cwha Read More Program effective Date: May 13, 2026
Provider QP32-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2026 Read More Program effective Date: May 13, 2026
Provider QP31-26 MHCP Pharmacy Benefit Exclusion for Avlayah™ and Qivigy™ Read More Program effective Date: May 13, 2026
Provider QP30-26 Commercial Pharmacy Benefit Exclusion for Avlayah™ and Qivigy™ Read More Program effective Date: May 13, 2026